AnchorDx appoints Dr. Marina Bibikova as Chief Scientific Officer

AnchorDx, a world-leading developer of cancer screening and early detection solutions, is delighted to announc...

March 7, 2022 | Monday | News
111, Inc & Beilin Pharma lay focus on digital marketing of Chinese patent medicines

111, Inc., a leading tech-enabled healthcare platform company in China, has signed a strategic cooperation agreement on ...

March 7, 2022 | Monday | News
I-Mab receives FDA orphan drug designation for cancer drug

China based I-Mab, a clinical-stage biopharmaceutical company committed to the discovery, development, and commercializa...

March 4, 2022 | Friday | News
China-based startup InxMed raises $50 M in Series B Financing

InxMed Co., Ltd, a clinical-stage biotechnology startup based in China, has announced that it had completed $5...

March 4, 2022 | Friday | News
Overland Pharmaceuticals Appoints Dr. Xun Liu as Chief Technology Officer

Overland Pharmaceuticals, a premier biopharmaceutical company bringing innovative medicines to patients in Asia and worl...

March 3, 2022 | Thursday | News
China's Adagene partners with French firm Sanofi for Immuno-Oncology

China's Adagene,  a company transforming the discovery and development of antibody-based therapies, has announced a...

March 3, 2022 | Thursday | News
China approves Phase II clinical trial of InnoCare's cancer drug

InnoCare Pharma, a leading biopharmaceutical company, has announced the Investigational New Drug (IND) approval of its B...

March 3, 2022 | Thursday | News
IASO Bio strengthens manufacturing of CAR-T cell therapy products in China

IASO Biotherapeutics, a clinical-stage biopharmaceutical company engaged in discovering, developing, and manufacturing i...

March 2, 2022 | Wednesday | News
Huadong becomes strategic partner in Asia for Heidelberg Pharma, strikes deal worth $0.9B

German firm Heidelberg Pharma AG and Huadong Medicine in China have entered into a strategic partner...

March 1, 2022 | Tuesday | News
China's CANbridge offers treatment for rare liver disease Alagille Syndrome

CANbridge Pharmaceuticals, Inc. has announced that CAN108 (maralixibat), a treatment for Alagille syndrome (ALGS), has b...

February 28, 2022 | Monday | News
Prenetics, ACON Bio to launch Flowflex COVID-19 at-home test in Hong Kong

Prenetics Group has partnered with ACON Bio to launch the Flowflex SARS-CoV-2 Antigen Rapid Test Kit in Hong Kong. ...

February 25, 2022 | Friday | News
Peli BioThermal opens first network station in China

Peli BioThermal, the life science industry’s cold chain partner from discovery to distribution, announces the open...

February 24, 2022 | Thursday | News
China approves world first clinical trial for 3D bio-printed stem cell vascular grafts

Revotek has received clearance from the National Health Commission of China to begin a clinical study in the W...

February 22, 2022 | Tuesday | News
China approves CanSinoBIO's Convidecia as heterologous booster for COVID-19

CanSino Biologics Inc. has announced that its Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector)...

February 21, 2022 | Monday | News
Hong Kong finds new inflammatory activation pathway in blood vessels after SARS-CoV-2 infection

A study led by The Chinese University of Hong Kong's (CUHK) Faculty of Medicine (CU Medicine) and the LKS Faculty of Med...

February 18, 2022 | Friday | News
Catalent expands temp-controlled clinical supply capabilities in China

US-based Catalent, the global leader in enabling biopharma, cell, gene, and consumer health partners to optimize develop...

February 16, 2022 | Wednesday | News
China gives conditional approval to Pfizer's oral COVID-19 drug

China's drug regulator National Medical Products Administration (NMPA) has granted conditional approval for the imports ...

February 15, 2022 | Tuesday | News
Hong Kong launches first handheld COVID-19 nucleic acid test

Pluslife Biotech, an enterprise based in the Greater Bay Area in Hong Kong, has launched the first handheld COVID-19 Nuc...

February 14, 2022 | Monday | News